Skip to content

Bio-Techne TECH Accrued compensation and employee benefits

Accrued compensation and employee benefits at other companies

Bruker logo
BrukerBRKR
Agilent Technologies logo
Agilent TechnologiesA
Charles River Laboratories logo
Charles River LaboratoriesCRL
International Flavors & Fragrances logo
International Flavors & FragrancesIFF
GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC

Other financials

Income statement

See full
Revenue$311.4M-1.5%
Gross profit$208.3M-2.9%
Operating income$75.5M+95.0%
Net income$51.0M+126%
EPS (diluted)$0.32+129%

Balance sheet

See full
Cash & equivalents$209.8M+49.2%
Total debt$290.3M-31.4%
Total equity$2.1B+3.3%
Total assets$2.6B-3.5%

Cash flow

See full
Operating cash flow$86.7M+111%
CapEx$9.1M-10.2%
Free cash flow$77.6M+150%

Valuation

See full
Market cap$9.07B-11.8%
Enterprise value$9.15B-13.6%
P/E60.6×+13.6×
P/S7.5×-1.0×

Profitability

See full
Gross margin65%-0.8pp
Operating margin14.2%-7.9pp
Net margin10.9%-6.7pp
FCF margin22.3%+4.0pp

Returns & leverage

See full
Return on equity6.5%-3.9pp
Debt / equity0.1×-0.1×
Current ratio4.5×+0.8×

Where this comes from

Reported directly by Bio-Techne in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities.

The official record: Bio-Techne’s 10-Q, filed November 5, 2025, on SEC EDGAR. View the filing →

Ask your AI about Bio-Techne's accrued compensation and employee benefits.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bio-Techne's accrued compensation and employee benefits?
Bio-Techne (TECH) reported accrued compensation and employee benefits of -$22.1M in Q3 2025.
How has Bio-Techne's accrued compensation and employee benefits changed year-over-year?
Bio-Techne's accrued compensation and employee benefits decreased by 168.0% year-over-year, from -$8.25M to -$22.1M.
What is the long-term trend for Bio-Techne's accrued compensation and employee benefits?
Over 3 years (2021 to 2025), Bio-Techne's accrued compensation and employee benefits has grown at a -9.1% compound annual growth rate (CAGR), from $20.54M to $15.41M.